EP
Eversept Partners Portfolio holdings
AUM
$992M
This Quarter Return
-21.28%
1 Year Return
+2.54%
3 Year Return
+103.47%
5 Year Return
+181.01%
10 Year Return
–
AUM
$380M
AUM Growth
+$380M
(-23%)
Cap. Flow
-$17.6M
Cap. Flow
% of AUM
-4.64%
Top 10 Holdings %
Top 10 Hldgs %
66.51%
Holding
81
New
10
Increased
16
Reduced
22
Closed
22
Top Buys
| 1 |
ZGNX
Zogenix, Inc.
ZGNX
|
$37.5M |
| 2 |
TG Therapeutics
TGTX
|
$16.6M |
| 3 |
Apellis Pharmaceuticals
APLS
|
$15.8M |
| 4 |
DCPH
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
|
$11.7M |
| 5 |
AMRN
Amarin Corp
AMRN
|
$10.4M |
Top Sells
| 1 |
GSK
GSK
|
$19.9M |
| 2 |
BOLD
Audentes Therapeutics, Inc
BOLD
|
$18.3M |
| 3 |
Vertex Pharmaceuticals
VRTX
|
$16M |
| 4 |
The Ensign Group
ENSG
|
$12M |
| 5 |
Sanofi
SNY
|
$11M |
Sector Composition
| 1 | Healthcare | 89.32% |
| 2 | Communication Services | 2.19% |
| 3 | Financials | 0.12% |
| 4 | Industrials | 0% |
| 5 | Real Estate | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
ZGNX
1
DELISTED
Zogenix, Inc.
ZGNX
| $49.8M | 12.38% | 2,013,467 +1,517,822 | +306% | +$37.5M |
|
2
Danaher
DHR
$147B
| $32.4M | 8.06% | 233,957 +36,850 | +19% | +$5.11M |
|
3
Ascendis Pharma
ASND
$11.8B
| $31M | 7.71% | 275,494 +72,600 | +36% | +$8.18M |
|
|
4
TG Therapeutics
TGTX
$4.65B
| $24.2M | 6.02% | 2,461,137 +1,684,814 | +217% | +$16.6M |
|
|
5
Apellis Pharmaceuticals
APLS
$3.48B
| $24.1M | 5.99% | 899,474 +589,065 | +190% | +$15.8M |
|
|
CCXI
6
DELISTED
ChemoCentryx, Inc.
CCXI
| $23.3M | 5.79% | 580,011 +66,822 | +13% | +$2.68M |
|
|
7
GSK
GSK
$79.9B
| $19.9M | 4.94% | 510,571 -512,514 | -50% | -$19.9M |
|
|
DCPH
8
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
| $17M | 4.24% | 414,081 +285,333 | +222% | +$11.7M |
|
9
AstraZeneca
AZN
$248B
| $15.7M | 3.91% | 352,551 +211,989 | +151% | +$9.47M |
|
10
BioCryst Pharmaceuticals
BCRX
$1.74B
| $15.1M | 3.75% | 7,542,372 +2,637,912 | +54% | +$5.28M |
|
|
AMRN
11
Amarin Corp
AMRN
$311M
| $14M | 3.48% | 3,504,062 +2,588,472 | +283% | +$10.4M |
|
|
12
The Ensign Group
ENSG
$9.91B
| $13.4M | 3.34% | 357,028 -319,030 | -47% | -$12M |
|
13
HCA Healthcare
HCA
$94.5B
| $9.07M | 2.26% | +101,000 | New | +$9.07M |
|
|
MODN
14
DELISTED
MODEL N, INC.
MODN
| $8.31M | 2.07% | 374,284 +166,669 | +80% | +$3.7M |
|
|
15
Sanofi
SNY
$121B
| $8.29M | 2.06% | 189,578 -252,083 | -57% | -$11M |
|
16
Fate Therapeutics
FATE
$120M
| $6.78M | 1.69% | 305,485 -55,171 | -15% | -$1.23M |
|
17
DexCom
DXCM
$29.5B
| $5.26M | 1.31% | 19,537 +7,487 | +62% | +$2.02M |
|
|
TARO
18
DELISTED
Taro Pharmaceutical Industries Ltd.
TARO
| $4.68M | 1.16% | 76,459 +71,506 | +1,444% | +$4.38M |
|
|
KDMN
19
DELISTED
Kadmon Holdings, Inc.
KDMN
| $4.09M | 1.02% | 975,350 -166,589 | -15% | -$698K |
|
20
Pennant Group
PNTG
$830M
| $4M | 0.99% | 282,181 -89,012 | -24% | -$1.26M |
|
|
MNTA
21
DELISTED
Momenta Pharmaceuticals, Inc.
MNTA
| $3.99M | 0.99% | +146,550 | New | +$3.99M |
|
|
RDUS
22
DELISTED
Radius Health, Inc.
RDUS
| $3.91M | 0.97% | 301,073 -17,738 | -6% | -$231K |
|
|
XLRN
23
DELISTED
Acceleron Pharma Inc.
XLRN
| $3.8M | 0.95% | +42,305 | New | +$3.8M |
|
|
BHVN
24
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
| $3.62M | 0.9% | +106,385 | New | +$3.62M |
|
25
Iovance Biotherapeutics
IOVA
$807M
| $2.7M | 0.67% | +90,047 | New | +$2.7M |
|